Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Journal of Skin and Stem Cell
  4. Articles

  5. Comparing Efficacy and Tolerability of Triamcinolone and Verapamil in Treatment of Hypertrophic Scars and Keloids
  6. Crossref

Journal of Skin and Stem Cell

The Official Journal of Skin and Stem Cell Research Center

Home
Current IssueAll IssuesIn PressSearchAccepted Manuscripts
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesPublication Ethics and Malpractice StatementSupportReviewer and AE Registration FormJournal MetricsContact UsOpen Peer Review (OPR)
Authors GuideSubmit Manuscript

Crossref


1. Letter to the Editor Regarding: Bao Y, Xu S, Pan Z, et al. Comparative Efficacy and Safety of Common Therapies in Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis. Aesth Plast Surg, 2019

- Pu Wang

- Luosha Gu

- Zelian Qin

2. Comparing the Efficacy and Safety of Intralesional Verapamil With Intralesional Triamcinolone Acetonide in Treatment of Hypertrophic Scars and Keloids: A Meta-Analysis of Randomized Controlled Trials

- Pu Wang

- Luosha Gu

- Hongsen Bi

- Qifei Wang

- Zelian Qin

3. Comparing the Effects of Mitomycin-C and Triamcinolone-Acetonide Injections on Hypertrophic Scars and Keloids in Burn Patients

- Jafar Jafarzadeh

- Mahtab Farhadi

- Nasrin Khodadadi

- Elham Farhadi

- Abdulreza Sheikhi

HomeInstructions

Articles

  • Current Issue
  • All Issues
  • In Press
  • Search
  • Accepted Manuscripts

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Publication Ethics and Malpractice Statement
  • Support
  • Reviewer and AE Registration Form
  • Journal Metrics
  • Contact Us
  • Open Peer Review (OPR)
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.